Suki Age and Identity Overview
Suki is widely recognized as an AI assistant integrated into clinical workflows, notably through Suki Assistant, which leverages voice and ambient documentation to support clinicians. Public profiles referencing Suki typically describe a technology persona rather than a single individual with a public birth date. In contexts where Suki refers to a person, the name is commonly associated with Japanese and Filipino cultures, though the specific individual referenced in popular queries is likely the AI product rather than a private person. This profile clarifies available, verifiable context for Suki in both technological and personal senses where documented.
Background and Public History
Suki emerged in public discourse primarily through the health technology startup Suki Inc., which announced Suki Assistant in 2018 and subsequently raised multiple funding rounds. The product is designed to reduce documentation burden for clinicians using voice input and ambient listening. Outside of this product, references to a person named Suki in media or entertainment are uncommon in widely indexed sources; when present, they often do not include precise biographical details. As a result, publicly confirmed biographical details remain limited for a private individual named Suki, while the product remains well-documented.
Suki Assistant Product Timeline
The product timeline below captures key verifiable events for Suki Assistant, which is the primary context for search interest. Because the product represents the principal entity called Suki in technology and business coverage, these milestones anchor most factual discussion.
| Date or Period | Event | Why It Matters |
|---|---|---|
| 2018 | Suki Assistant announced | Established Suki as a voice-first clinical documentation tool |
| 2019 | Series A and seed funding totaling $20 million reported | Signaled investor confidence and product development runway |
| 2021 | Series B funding of $44.5 million disclosed | |
| 2022 onward | Continued enterprise deployments and integration announcements | Reflected sustained product presence in healthcare workflows |
Estimated Age Range Where Applicable
If the query refers to a private individual named Suki with limited public presence, reliable age or birth-year data are generally unavailable in authoritative sources. Any cited age would be an unverified estimate and should be treated as such. By contrast, the product Suki Assistant does not have an age; it has a version history and release timeline, which are neutral with respect to biological aging. Consequently, age relevance is context-dependent and most reliably tied to the product’s maturity rather than a person’s biography.
Relationship and Role Context
In healthcare and technology contexts, Suki is primarily positioned as an assistant tool designed to work alongside clinicians and administrative staff. The relationship is professional and functional, centered on documentation, voice commands, and workflow integration. If referring to a person named Suki in a familial, romantic, or social context, publicly sourced evidence is sparse. Without confirmed public statements from the individual or their representatives, relationship statements remain speculative and should be approached with caution.
Notable Details and Transparency
- Primary public entity named Suki is a product, not a person, in the technology and healthcare sectors.
- Funding rounds in 2019 and 2021 are documented in press releases and Crunchbase-style registries.
- No widely circulated, authoritative biography confirms a specific person’s age, birth date, or detailed personal history for an individual named Suki.
- Product updates after 2022 indicate ongoing maintenance, but do not provide personal attributes of a namesake individual.
Factual Summary Table
The table below summarizes the most reliably attributable metrics for Suki at the time of writing. Items are drawn from public announcements and investor disclosures where available.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Product name | Suki Assistant | Company announcements |
| Initial public mention | 2018 | Press release |
| Series A and seed funding | $20 million reported | Company press release, 2019 |
| Series B funding | $44.5 million disclosed | Company press release, 2021 |
| Primary function | Ambient clinical documentation | Product materials |
| Documented integrations | EHR integrations announced | Partnership announcements |
Comparisons and Context
Compared to other widely adopted clinical documentation tools, Suki Assistant positions itself as voice-centric and clinician-focused. Key comparative signals include funding scale, enterprise deployment count, and feature specificity. While exact user counts are rarely disclosed in detail, the product appears concentrated in U.S. health systems where ambient AI documentation is actively evaluated. This context helps users gauge Suki’s footprint without inferring personal attributes of a private individual bearing the same name.
Status and Clarification
As of the current date, there is no publicly confirmed information about a private individual named Suki with verifiable age, birth date, or biographical timeline. The dominant, evergreen context for the term is the Suki Assistant product, whose milestones are documented through company announcements and funding disclosures. Seeking personal details about a non-public person named Suki would likely encounter significant source gaps and unverifiable speculation. Users are advised to anchor their understanding on the product timeline and to treat unverified personal claims with skepticism.
Summary and Takeaways
Suki is best understood through the lens of its primary public manifestation, Suki Assistant, a clinical documentation tool launched in 2018 with multiple funding rounds in 2019 and 2021. If referring to a person, reliable age or background details are not available in authoritative public sources; any specifics would be speculative. This profile clarifies product context, funding milestones, and source reliability to support long-term, fact-first reference.